Research and Development
Five Facts about mental health
May 21, 2025 Medical Communications, Medical Education, Research and Development European Commission, Pharmacy, Psychiatry, mental health, mental health condition
Novartis releases new data across oncology and haematology pipelines
May 21, 2025 Research and Development ASCO, EHA, Haematology, Novartis, Oncology, oncology
Slingshot Therapeutics appoints Ed Savory as head of chemistry
May 21, 2025 Research and Development Corporate, Pharmacy, Slingshot Therapeutics, appointment
BioPhorum appoints Uwe Buecheler as non-executive director
May 21, 2025 Medical Communications, Research and Development BioPhorum, Corporate, appointment, biopharma, medical communication
Multiple myeloma treatment approved in Japan
May 21, 2025 Market Access, Research and Development, Sales and Marketing GSK, Japan, Oncology, Orphan Drug Designation (ODD), multiple myeloma
FDA approves Incyte’s new anal cancer treatment
May 20, 2025 Research and Development FDA, Incyte Corporation, Oncology, Orphan Drug Designation (ODD), Zynyz, fast track designation, priority review
Landmark BioVentures launches spin-off biotech to tackle fibrotic, neoplastic and neovascularised conditions
May 20, 2025 Research and Development Aix-Marseille University, Cardiology, Corporate, Landmark BioVentures, Massalia Therapeutics, Oncology, cardiovascular research, oncology
FDA approves diagnostic tool for MET-targeted lung cancer therapy
May 19, 2025 Research and Development FDA, Oncology, Roche, lung cancer, non-squamous non-small cell lung cancer
Cold plasma therapy shown to be 100% effective against pneumonia-causing bacteria
May 19, 2025 Research and Development Infections and infestations, MRSA, Viromed Medical, intensive care, lung therapy, ventilator-associated pneumonia (VAP)
Medable unveils oncology trial platform aimed at reducing logistical hurdles
May 16, 2025 Biotech/start-up, Business Services, Research and Development, Sales and Marketing, Technical Consultancy AI, FDA, Medable, Oncology, digital platform, oncology research, oncology trials
Moleculin secures EMA approval to expand acute myeloid leukaemia trial across EU
May 16, 2025 Research and Development Clinical Trial Application (CTA), European Union (EU), FDA, Food and Drug Administration, Moleculin Biotech, Oncology, Orphan Drug Designation (ODD), acute myeloid leukaemia
Hansa Biopharma data demonstrates potential of imlifidase in Guillain-Barré syndrome
May 15, 2025 Research and Development Guillain-Barré Syndrome (GBS), Hansa Biopharma, Immunology, Peripheral Nerve Society (PNS) Annual Meeting, Rare Diseases
Kaerus Bioscience secures FDA approval for rare genetic disorder treatment
May 15, 2025 Research and Development FDA, Fragile X syndrome, Kaerus Bioscience, Orphan Drug Designation (ODD), Rare Diseases, Rare Pediatric Drug Designations (RPDD), genetic syndromes
Secarna Pharmaceuticals and Curie.Bio portfolio company enter research and option agreement
May 14, 2025 Research and Development Corporate, Cure.Bio Portfolio Company, Pharmacy, Secarna Pharmaceuticals, agreement
Tozaro forms Technical Advisory Board to accelerate Smart Polymer commercialisation for CGT bioprocessing
May 14, 2025 Manufacturing and Production, Research and Development CGT production, Cell and Gene Therapy (CGT), Contraception, Pharmacy, Tozaro, advisory board
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
